Petros Grivas, MD, PhD, discusses the challenge with biomarker discovery currently in the treatment landscape of urothelial carcinoma.
Peter Grivas, MD, PhD
Advertisement
Articles by Peter Grivas, MD, PhD
Peter Grivas, MD, PhD, discusses the next steps necessary for the treatment landscape of advanced urothelial cancer to evolve.
Advertisement
Latest Updated Articles
Improving Biomarker Discovery and Development in Urothelial CarcinomaPublished: September 20th 2020 | Updated:
Expert Highlights Next Steps to Evolve the Treatment Landscape of Urothelial CancerPublished: April 4th 2019 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
4
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
5
